Brenton Reynolds

FA Investor, Stock Broker & Corporate Advisor. Assume I own shares, or am retained by the companies I tweet about. None of my tweets should be considered advice

[John Quakes @quakes99]

🔥At his confirmation hearing today, US @ENERGY Secretary nominee Chris Wright responds to questions on the need to restore US #Nuclear fuel infrastructure, #Uranium #mining & enrichment⚛️⛏️🇺🇸 and end dependence on foreign actors, #Russia & #China 🤠🐂🌊🏄

[Codrus Minerals Limited @CodrusMinerals]

Codrus Minerals will be attending the upcoming @RR_Stars Gold Coast Conference, 16-17 May 2023.

Ahead of the event, our Managing Director @ShannanBamforth caught up with the RRS team to discuss the 2,000m RC maiden drilling program underway at our niobium-rich, high-grade Karloning Rare Earth Project in Western Australia.

Our Karloning Project represents an exciting growth and diversification opportunity in the REE sector; read more about current activities underway at the project here: https://t.co/DsNFhEGbLv

$CDR

[NeuroScientific Biopharmaceuticals @NSB_biopharma]

📣 ASX ANNOUNCEMENT 📣
Positive Safety Results For EmtinB™ Supports Advancement to First-In-Human Clinical Trial

See 👇🎥 for highlights.
$NSB #MultipleSclerosis #Alzheimers #Glaucoma #neurodegeneration

https://t.co/Z6lamD2ATy

[Top End Energy Ltd @TopEndEnergy]

The Morrison government has identified the #Beetaloo Basin as an area with significant gas potential, and a cornerstone of its gas expansion plans

$TEE #NT #GAS #LNG #Energy #ESG
https://t.co/ZYAkIWbaqP

[Brenton Reynolds @BigBSReynolds]

@lazyschmitt What about a cheeky MDLND drop. Pay homage to your roots bro

[NeuroScientific Biopharmaceuticals @NSB_biopharma]

📣ASX ANNOUNCEMENT📣
New Data Demonstrates EmtinB Regulates Key Drivers of Chronic Inflammation and Autoimmune Diseases

See 🎥👇for highlights.
$NSB #EmtinB

🔗https://t.co/mXHvN98njS

[Brenton Reynolds @BigBSReynolds]

@giginator_

[Brenton Reynolds @BigBSReynolds]

@CharlieMunger00 @timarmstrong90

[NeuroScientific Biopharmaceuticals @NSB_biopharma]

$NSB has reported positive outcomes from genotoxicity & plasma protein binding studies confirming:

✅ A key safety milestone for #EmtinB
✅ Independent safety analysis confirms #EmtinB is suitable for Phase I trials - due 1H CY22

#neuroscience #alzheimers #MS #glaucoma
🔬🧪👩‍🔬

[Fortescue Future Industries @FortescueFuture]

We’re acquiring a stake in Sparc Hydrogen, who are developing next-generation technology to produce 100% renewable #GreenHydrogen using only sunlight and water. ☀️ 💧

[NeuroScientific Biopharmaceuticals @NSB_biopharma]

$NSB Dec 21 Q highlights:

✅ Completion of safety pharmacology & off-target assessment
✅ Initiated toxicity studies to allow Phase I to commence
✅ Partnered with leading research groups
✅ Positive biomarker data for Emtin peptides
✅ Interest from #BigPharma
✅ $9.5m cash

[Brenton Reynolds @BigBSReynolds]

He ain’t wrong

[mikey @mikeymifsud]

Time zones are crazy, it’s 11:15 in Melbourne it’s it’s 10:45 in Adelaide and it’s 2020 in Western Australia

[Brenton Reynolds @BigBSReynolds]

Looking forward to a big year from Noronex. Class A exploration team in a Class A copper belt. #held #copper #Namibia

[Noronex_NRX @Noronex2]

Noronex is looking forward to an exciting year ahead in 2022. #Copper #Namibia #exploration

[Sarytogan Graphite @Sarytogan]

The #Graphite market continues to show signs of strength, moving into deficit in 2022

Demand expected to grow 30% annually until 2030, with natural Graphite the preferred choice for OEMs #EV #Battery
https://t.co/XSRSlZdnyS

[Brenton Reynolds @BigBSReynolds]

@coastlife89 Really looking forward to seeing the grade on that 50m intercept. Fingers crossed it’s moon time.

[NeuroScientific Biopharmaceuticals @NSB_biopharma]

It's #GlaucomaAwarenessMonth. Currently, there are no treatments available that are able to reverse damage done to the optic nerve once it has occurred. However, NSB looks forward to trialing #EmtinB in 2022 with view to changing this paradigm https://t.co/5R2fTsjmij

[Brenton Reynolds @BigBSReynolds]

@TwinTurboCe1ica Good from you

[Brenton Reynolds @BigBSReynolds]

@alex_rovira7 @DanielRootes29 That’s why I lost my smell. Had to be the Rona

[NeuroScientific Biopharmaceuticals @NSB_biopharma]

$NSB has taken another step toward Phase I studies for lead peptide #EmtinB by confirming:

✅ the drug did not interact with any known targets known to cause adverse reactions or toxicities in humans

🔬🧪

ASX 🔗: https://t.co/LvriWnPXid

[NeuroScientific Biopharmaceuticals @NSB_biopharma]

$NSB's recent biomarker studies indicate:

✅Peptide candidates regulate inflammatory & immune biomarkers
✅EmtinAC regulate TNF⍶ - target of $20B/y drug Humira
✅EmtinAN decreased biomarkers for lung inflammation
✅EmtinBN modulated biomarkers of tissue repair & wound healing